Dr. Sijo Parekattil

Dr. Sijo Parekattil
Dr. Sijo Parekattil is Director of Avant Concierge Urology, Winter Garden, FL and an Associate Professor of Urology at the University of Central Florida (UCF). He was an Electrical Engineer (University of Michigan) prior to his medical training and thus has interests in surgical techniques incorporating technology, robotics and microsurgery. He completed his urology residency training at Albany Medical Center and then went onto complete dual fellowship training from the Cleveland Clinic Foundation, Cleveland in Laparoscopy/Robotic Surgery and Microsurgery/Male Infertility. He is one of the only urologists in the country with this type of dual fellowship training background. Dr. Parekattil has received numerous awards including two Annual Innovator Awards from the Cleveland Clinic Foundation and the Golden Garland Award in Medicine in 2012. He has published several articles in the field of robotic microsurgery and microsurgery. He is an editor on a few textbooks on Male Infertility and a surgical textbook on Robotic Microsurgery. He has performed some pioneering work in the arena of microsurgery and has performed well over 3000 such procedures. He has developed a multi-disciplinary program dedicated to the treatment of male infertility and groin/testicular pain. He is also a Visiting Professor at the University of Zambia, Lusaka, Africa. He is one of the founding Board members of the Robotic Assisted Microsurgical & Endoscopic Society (RAMSES), a group focused on the evidence-based development of tools and platforms for robotic-assisted microsurgery, and the International Microsurgical Simulation Society (IMSS), a group focused on developing more standardized and effective microsurgical training techniques. He is on the foundation board for the Florida Polytechnic University, Lakeland, FL, and an Executive Board Member of the Florida Urological Society. Avant Concierge Urology: Sijo J. Parekattil, MD
Medical School:

Albany Medical Center

Fellowship:

Cleveland Clinic

Undergraduate:

University of Michigan

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only